FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Abciximab (ReoPro) Injection
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Janssen Biotech, Inc. (Revised 08/15/2019)

Company Contact Information:
800-586-7736

Presentation Posting Date Related Information
2mg/mL (NDC 57894-200-01) 08/15/2019 Janssen has made a business decision to discontinue manufacture of the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English